Protalix BioTherapeutics
PLX
#8710
Rank
$0.10 B
Marketcap
$1.40
Share price
-0.71%
Change (1 day)
-0.71%
Change (1 year)

Protalix BioTherapeutics (PLX) - Cash on Hand

Cash on Hand as of June 2024 : $45.02 Million USD

According to Protalix BioTherapeutics 's latest financial reports the company has $45.02 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Protalix BioTherapeutics - Cash on Hand chart (from 1999 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$44.56 M100.9%
2022-12-31$22.18 M-43.11%
2021-12-31$38.98 M1.14%
2020-12-31$38.54 M116.64%
2019-12-31$17.79 M-52.94%
2018-12-31$37.8 M-26.1%
2017-12-31$51.16 M-19.15%
2016-12-31$63.28 M-17.14%
2015-12-31$76.37 M39.45%
2014-12-31$54.76 M-36.61%
2013-12-31$86.39 M66.04%
2012-12-31$52.03 M92.72%
2011-12-31$27 M-24.79%
2010-12-31$35.9 M-55.82%
2009-12-31$81.26 M90.78%
2008-12-31$42.59 M-31.09%
2007-12-31$61.81 M169.28%
2006-12-31$22.95 M384.18%
2005-12-31$4.74 M740.6%
2004-12-31$0.56 M-22.93%
2003-12-31$0.73 M-9.39%
2002-12-31$0.8 M-11.79%
2001-12-31$0.91 M-43.06%
2000-12-31$1.6 M9.45%
1999-12-31$1.46 M13.94%
1998-12-31$1.28 M135.33%
1997-12-31$0.54 M-28.28%
1996-12-31$0.76 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.24 B 454.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.22 B 2,627.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.95 B 22,001.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.31 B 7,270.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel